Loveless Wealth Management’s Integra LifeSciences IART Stock Holding History

Loveless Wealth Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$394K	Buy	7,290 +20	+0.3%	+$1.2K	0.26%	95
2022 Q1	$467K	Hold	7,270	–	–	0.26%	98
2021 Q4	$487K	Hold	7,270	–	–	0.27%	100
2021 Q3	$498K	Hold	7,270	–	–	0.3%	93
2021 Q2	$496K	Hold	7,270	–	–	0.3%	93
2021 Q1	$502K	Hold	7,270	–	–	0.33%	88
2020 Q4	$472K	Sell	7,270 -275	-4%	-$14.8K	0.35%	85
2020 Q3	$356K	Hold	7,545	–	–	0.3%	84
2020 Q2	$355K	Sell	7,545 -50	-0.7%	-$2.46K	0.33%	79
2020 Q1	$339K	Hold	7,595	–	–	0.4%	71
2019 Q4	$435K	Buy	+7,595	New	+$452K	0.38%	73

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loveless Wealth Management's IART Position: Q2 2022 in Review

Loveless Wealth Management increased its Integra LifeSciences (IART) stake by 0.28% in Q2 2022, buying an estimated $1.2K and bringing the position to 7,290 shares worth $394K. The position accounts for 0.26% of the portfolio, ranked #95.

Loveless Wealth Management first reported a position in IART in Q4 2019 and has held it in 11 quarters since. The position peaked at $502K in Q1 2021. 284 funds tracked by Wall St. Rank hold IART as of Q2 2022.

Loveless Wealth Management held 7,290 shares of Integra LifeSciences worth $394K as of Q2 2022.
Loveless Wealth Management bought 20 Integra LifeSciences shares in Q2 2022, an estimated $1.2K.
Integra LifeSciences made up 0.26% of Loveless Wealth Management's portfolio in Q2 2022, its #95 holding.
Loveless Wealth Management first reported a position in Integra LifeSciences in Q4 2019 and has held it in 11 quarters since.
Loveless Wealth Management's Integra LifeSciences position peaked at $502K in Q1 2021.
284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2022.

Based on Loveless Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.